Invasive Group A Streptococcus Toxic Shock Syndrome, Myositis, and Probable Necrotizing Fasciitis in Pemphigus Vulgaris - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Invasive Group A Streptococcus Infection Leading to Toxic Shock Syndrome, Myositis, and Likely Necrotizing Fasciitis in a Patient with Pemphigus Vulgaris

  • October 6, 2026

Share

Clinical Scorecard: Invasive Group A Streptococcus Infection Leading to Toxic Shock Syndrome, Myositis, and Likely Necrotizing Fasciitis in a Patient with Pemphigus Vulgaris

At a Glance

Category

Detail

Condition

Invasive Group A Streptococcus Infection

Key Mechanisms

Toxic shock syndrome, myositis, necrotizing fasciitis

Target Population

Patients with pemphigus vulgaris

Care Setting

Multidisciplinary hospital care

Key Highlights

  • 50% prevalence of skin and soft tissue infections in pemphigus vulgaris patients

  • Mortality associated with invasive group A streptococcal infection ranges from 70% to 100%

  • First report of invasive group A streptococcal infection during active pemphigus vulgaris flare

  • Empirical antibiotic therapy included ceftriaxone, vancomycin, and piperacillin-tazobactam

  • Clindamycin was used for toxin suppression in the setting of severe infection

Guideline-Based Recommendations

Diagnosis

  • Diagnosis established by clinical presentation and blood cultures

Management

  • Initiate broad-spectrum antibiotics and adjust based on culture results

  • Consider high-dose intravenous penicillin G for severe infections

Monitoring & Follow-up

  • Monitor for signs of compartment syndrome and necrotizing fasciitis

  • Regularly assess inflammatory markers and leukocytosis

Risks

  • High morbidity and mortality associated with invasive group A streptococcal infections

  • Potential for complications due to immunosuppressive therapy in pemphigus vulgaris

Patient & Prescribing Data

Individuals with pemphigus vulgaris experiencing severe exacerbations

Combination therapy with clindamycin and high-dose penicillin G is critical for managing severe infections

Clinical Best Practices

  • Employ a multidisciplinary approach for complex cases involving infections in immunocompromised patients

  • Early identification and intervention for signs of severe infection are essential

Related Resources & Content

  1. Association of serious infections with pemphigus and pemphigoid: analysis of the Nationwide Inpatient Sample.

  2. MDSpire News — Necrotizing Fasciitis Following Minor Bike Injury

  3. Infection — Clostridium septicum-Induced Gas Gangrene in a Patient with Neutropenia

  4. Infection — The Evolving Epidemiology of Invasive Group A Streptococcus in Tropical Australia: Insights from a 21-Year Population-Based Data Analysis

  5. International Journal of Infectious Diseases — Skin biopsy PCR enables rapid diagnosis of tattoo-associated staphylococcal toxic shock syndrome

  6. Clinical Guidance for Type II Necrotizing Fasciitis | Group A Strep | CDC

  7. Severe Group A Streptococcus Infection among Children, France, 2022–2024 - Volume 31, Number 9—September 2025 - Emerging Infectious Diseases journal - CDC

  8. Association of serious infections with pemphigus and pemphigoid: analysis of the Nationwide Inpatient Sample.

Original Source(s)

Related Content